BioWorld MedTech

July 18, 2019

Paragon Biosciences unveils Qlarity Imaging to advance Quantx system

Chicago-based Paragon Biosciences LLC has launched its seventh portfolio company, Qlarity Imaging LLC, which will focus on further developing Quantx, an FDA-cleared, computer-aided breast cancer diagnosis system. Read More

Endotronix enrolls first patient in CE mark trial for pulmonary artery pressure sensor

Casetabs secures $3M for surgical coordination tech

Industry seeks clarity in FDA's draft rule on radiological health regs

To treat or not to treat? Machine learning has answers

Regulatory front

Financings

Daily M&A

Appointments and advancements

Other news to note

Product regulatory actions for July 17, 2019

BioWorld MedTech's Orthopedics Extra

Today's news in brief

BioWorld

BioWorld briefs for July 10, 2026.

3D rendering of an antibody drug conjugate

‘Target-high but uptake-defective’ state identified in ADC resistance

BioWorld

Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...

Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy

BioWorld

News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...

FENS 2026: Shedding light on the sheddome

BioWorld

At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...

FENS 2026: Next-gen biologics take on brain disease

BioWorld

Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...